Loading...
Hydroxyurea-induced cutaneous squamous cell carcinoma: A case report
BACKGROUND: Hydroxyurea (HU) is a non-alkylating antineoplastic agent that is active in the S-phase of the cell cycle and inhibits the enzyme ribonucleoside reductase. HU is currently used to treat leukemia, sickle cell anemia, psoriasis, and chronic myeloproliferative disorders. Although HU is easy...
Saved in:
| Published in: | World J Clin Cases |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Baishideng Publishing Group Inc
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906572/ https://ncbi.nlm.nih.gov/pubmed/31832413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i23.4091 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|